<DOC>
	<DOC>NCT02837744</DOC>
	<brief_summary>To evaluate Safety and Efficacy of Axiostat® hemostatic dressing as compared to Standard Institutional Care product in terms of time to achieve hemostasis, post application complication and comfort levels of patients.</brief_summary>
	<brief_title>Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure</brief_title>
	<detailed_description>To evaluate Safety and Efficacy of Axiostat® hemostatic dressing as compared to Standard Institutional Care product in terms of time to achieve hemostasis, post application complication and comfort levels of patients who have undergone radial intervention.</detailed_description>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>1. Age greater than or equal to 18 years. 2. Patient and/or patient's legal representative and/or impartial witness has/have been informed of the nature of the study and agrees to its provision and has provided written informed consent as approved by the Ethics Committee of the investigative site. 3. Iatrogenic puncture 4. Patient who want to undergo radial intervention. 5. All puncture size must be less than 2.5cm. 1. Prior diagnosis of disease or medical condition affecting the ability of blood to clot (e.g., hemophilia.). 2. Patients with known sensitivity to chitosan (shellfish) used in this study. 3. Patients who, in the opinion of the Investigator, may not complete the study for any reason, e.g. Patient requiring Immediate suturing. 4. Patient is currently participating in an investigational drug or dressing study that has not yet completed its primary endpoint interferes with procedure and assessments in this trial. 5. Pregnant women. 6. Patients with hemorrhagic shock. 7. Patient having hemoglobin &lt; 9 g/dl.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>